Munich Reinsurance Co Stock Corp in Munich Invests $47.53 Million in CVS Health Corporation $CVS

Munich Reinsurance Co Stock Corp in Munich purchased a new position in shares of CVS Health Corporation (NYSE:CVS) during the second quarter, HoldingsChannel.com reports. The institutional investor purchased 459,492 shares of the pharmacy operator’s stock, valued at approximately $47,534,000.

Several other institutional investors have also recently bought and sold shares of the business. BlackRock Inc. bought a new stake in shares of CVS Health during the second quarter valued at approximately $12,747,462,000. State Street Corp raised its position in CVS Health by 2.1% in the 4th quarter. State Street Corp now owns 60,183,743 shares of the pharmacy operator’s stock worth $4,776,182,000 after purchasing an additional 1,245,457 shares during the last quarter. Wellington Management Group LLP lifted its holdings in CVS Health by 49.8% during the 2nd quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator’s stock worth $3,496,725,000 after buying an additional 11,233,381 shares in the last quarter. Capital International Investors boosted its position in CVS Health by 3.4% in the 4th quarter. Capital International Investors now owns 27,592,356 shares of the pharmacy operator’s stock valued at $2,189,793,000 after buying an additional 900,153 shares during the last quarter. Finally, Bank of America Corp DE increased its stake in shares of CVS Health by 148.0% in the 2nd quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock valued at $2,398,868,000 after buying an additional 13,836,701 shares during the period. Institutional investors own 80.66% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently issued reports on CVS shares. Wells Fargo & Company raised their price target on CVS Health from $103.00 to $123.00 and gave the company an “overweight” rating in a report on Monday, July 13th. Piper Sandler reissued an “overweight” rating on shares of CVS Health in a report on Wednesday, August 26th. Truist Financial raised their target price on shares of CVS Health from $108.00 to $118.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Weiss Ratings upgraded shares of CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, August 5th. Finally, Sanford C. Bernstein increased their price objective on shares of CVS Health from $94.00 to $106.00 and gave the company an “outperform” rating in a report on Tuesday, May 12th. Twenty-two equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $106.83.

CVS Health Stock Down 0.4%

NYSE:CVS opened at $96.80 on Friday. CVS Health Corporation has a 1 year low of $69.51 and a 1 year high of $110.68. The stock has a 50-day moving average price of $100.79 and a two-hundred day moving average price of $90.14. The stock has a market cap of $123.80 billion, a price-to-earnings ratio of 25.61, a PEG ratio of 0.95 and a beta of 0.59. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, beating the consensus estimate of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The business had revenue of $106.10 billion for the quarter, compared to analysts’ expectations of $100.03 billion. During the same quarter in the previous year, the business posted $1.81 EPS. CVS Health’s revenue for the quarter was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, equities analysts expect that CVS Health Corporation will post 8.02 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were paid a $0.665 dividend. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 2.7%. CVS Health’s payout ratio is presently 70.37%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.